SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy

Conclusions: SLE-DAS was highly correlated with SLEPDAI and its use in the first trimester predicted maternal flares in the 2nd and 3rd trimester, making SLE-DAS a reliable instrument to measure SLE activity during pregnancy.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research